Airways Clinical Research Centers - SAPS | American Lung Association

Location Select your location

Airways Clinical Research Centers - SAPS

Research Awards Nationwide Recipient (2013-2015)

About 20 percent of all people with asthma smoke. Smokers are consistently excluded from therapeutic trials for asthma. As a result current asthma treatment guidelines may not be appropriate for smokers. Indeed, there is good evidence that inhaled corticosteroids, the mainstay for treating persistent asthma, are less effective in smokers. The SAPS trial is designed to test the feasibility of a large scale clinical trial looking at the four main therapeutic options for asthmatic patients who still smoke and are not well controlled on standard asthma therapy. Smoking cessation remains the primary strategy for treating these patients but this study represents an important step toward improving care for that significant population of individuals with asthma for whom smoking cessation remains a struggle.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.


LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.